[Asia Economy Reporter Minji Lee] Celltrion Healthcare announced on the 10th that it has decided to acquire its own shares worth 50 billion KRW to stabilize its stock price and enhance shareholder value. The expected acquisition period is from the 11th to April 10th.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing